A Study of SANGUINATE for the Treatment of Vaso-occlusive Crisis (VOC) in Adult Sickle Cell Disease Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions

Anemia, Sickle Cell

Interventions

DRUG

SANGUINATE 320 mg/kg

Two-hour infusion of SANGUINATE on Day 1 and Day 2

DRUG

Normal Saline

Two-hour infusion of Normal Saline and Day 1 and Day 2

Trial Locations (4)

Bogotá

Santo Domingo

San Pedro Sula

Panama City